Skip to content

Minimum Effective Volume of Bupivacaine for Serratus Posterior Superior Intercostal Plane Block in Video-Assisted Thoracoscopic Surgery

Determination of the Median Effective Volume (ED50) of Bupivacaine for Serratus Posterior Superior Intercostal Plane Block in Patients Undergoing Video-Assisted Thoracoscopic Surgery Using the Dixon Up-and-Down Method

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07446959
Acronym
SPSIP-EV50
Enrollment
27
Registered
2026-03-03
Start date
2026-03-15
Completion date
2026-07-15
Last updated
2026-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain Management, Video-assisted Thoracoscopic Surgery (VATS)

Keywords

SPSIP Block, Regional Anesthesia, Dose-Finding Study, Dixon Up-and-Down Method, Thoracic Analgesia

Brief summary

This study aims to determine the minimum effective volume of bupivacaine required for the serratus posterior superior intercostal plane (SPSIP) block in patients undergoing video-assisted thoracoscopic surgery (VATS). The SPSIP block is an ultrasound-guided regional anesthesia technique used to provide postoperative pain relief after thoracic surgery. Using a stepwise dose-adjustment method, the volume of local anesthetic will be increased or decreased based on the effectiveness of the block in each patient. The main outcome of the study is to identify the volume that provides effective pain control in 50% of patients. The results may help optimize pain management while minimizing drug exposure.

Detailed description

This prospective interventional dose-finding study is designed to determine the median effective volume (ED50) of 0.25% bupivacaine for ultrasound-guided serratus posterior superior intercostal plane (SPSIP) block in patients undergoing video-assisted thoracoscopic surgery (VATS). The up-and-down sequential allocation method described by Dixon and Massey will be used. The initial volume of bupivacaine will be administered to the first patient, and subsequent volumes will be adjusted in 2 mL increments according to the response of the preceding patient. If the block is successful, the volume for the next patient will be decreased by 2 mL. In case of block failure, the volume will be increased by 2 mL. Block success will be defined as the presence of sensory loss to cold in at least two consecutive dermatomes between T3 and T6, assessed 20-30 minutes after block performance, combined with a cumulative fentanyl requirement of less than 2 µg/kg within the first 60 minutes after induction of general anesthesia. Failure will be defined as absence of adequate sensory blockade or the need for fentanyl ≥2 µg/kg. The up-and-down sequence will be continued until nine reversal points are obtained. The ED50 will be calculated as the mean of the midpoint doses of all independent success-failure pairs. Secondary outcomes will include postoperative pain scores and opioid consumption. This study aims to provide clinically relevant data to optimize the volume of local anesthetic for SPSIP block while maintaining effective analgesia and minimizing potential adverse effects.

Interventions

Ultrasound-guided serratus posterior superior intercostal plane block performed prior to general anesthesia in patients undergoing video-assisted thoracoscopic surgery (VATS). A 0.5% bupivacaine solution is injected, and the volume is adjusted in 2 mL increments according to the Dixon up-and-down sequential allocation method to determine the median effective volume (ED50).

Sponsors

Bursa City Hospital
Lead SponsorOTHER_GOV
Ulusoy, Emre, M.D.
CollaboratorINDIV

Study design

Allocation
NA
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Sequential dose-adjustment design using the Dixon up-and-down method, in which local anesthetic volume is increased or decreased in fixed 2 mL steps based on the success or failure of the preceding block.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years or older * Scheduled for elective video-assisted thoracoscopic surgery (VATS) * American Society of Anesthesiologists (ASA) physical status I-III * Planned to receive ultrasound-guided serratus posterior superior intercostal plane block for postoperative analgesia * Ability to provide written informed consent

Exclusion criteria

* Refusal to participate in the study * Known allergy or contraindication to local anesthetics * Infection at the block injection site * Coagulation disorders or anticoagulant therapy contraindicating regional anesthesia * Severe respiratory insufficiency * Chronic opioid use or chronic pain syndrome * Pregnancy * Inability to cooperate or communicate postoperative pain scores

Design outcomes

Primary

MeasureTime frameDescription
Median Effective Volume (ED50) of 0.5% Bupivacaine for Successful SPSIP BlockWithin the first 30 minutes after block performanceThe median effective volume (ED50) of 0.5% bupivacaine required to achieve successful postoperative analgesia following ultrasound-guided serratus posterior superior intercostal plane block, determined using the Dixon up-and-down sequential allocation method.

Secondary

MeasureTime frameDescription
Postoperative Pain Scores (NRS)Up to 24 hours postoperativelyNumerical Rating Scale (NRS) pain scores ranging from 0 to 10, where 0 represents no pain and 10 represents the worst imaginable pain, assessed at rest and during movement at 0, 1, 2, 4, 8, 12, and 24 hours after surgery.
Postoperative Morphine Consumption via Patient-Controlled Analgesia (PCA)First 24 hours after surgeryTotal cumulative morphine dose administered through patient-controlled analgesia (PCA) within the first 24 postoperative hours, measured in milligrams. Higher values indicate increased analgesic requirement.
Postoperative Adverse EffectsUp to 24 hours postoperativelyIncidence of opioid- and block-related adverse effects including nausea, vomiting, pruritus, dizziness, hypotension, respiratory depression, and local complications at the block site.
Quality of Recovery Score (QoR-15)24 hours after surgeryQuality of Recovery assessed using the 15-item Quality of Recovery questionnaire (QoR-15), with scores ranging from 0 to 150, where higher scores indicate better postoperative recovery.
Postoperative Pulmonary Function ParametersPreoperative baseline and 24 hours after surgeryPulmonary function assessed using spirometric parameters including forced vital capacity (FVC) and forced expiratory volume in one second (FEV1) measured preoperatively and at 24 hours postoperatively.

Countries

Turkey (Türkiye)

Contacts

CONTACTemre ulusoy
emreulusoy36@gmail.com+905379492799

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 13, 2026